In EIAS 2 populations of insulin antibodies have been demonstrated: the first with low affinity/high capacity (commonly associated with postprandial hyperglycemia and nocturnal hypoglycemia) and the second high affinity/low capacity (typically accompanied by severe insulin resistance) [2]. This evidence concerns the gene INS and Hypoglycemia.